Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026
Inspire Medical Systems (NYSE: INSP) will release its second quarter 2026 financial results after the market close on Monday, August 3, 2026.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) will release its second quarter 2026 financial results after the market close on Monday, August 3, 2026. Management will host a conference call at 5:00 p.m. Eastern Time, with access via webcast and phone registration links.
Positive
- None.
Negative
- None.
Details
News Market Reaction – INSP
On Jul 6, the day this news came out, INSP closed 5.32% above the previous close. Our momentum scanner recorded 7 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 6 session.
Key Figures
- Q2 2026 release date
- August 3, 2026
- Second quarter 2026 financial results release after market close
- Earnings call time
- 5:00 p.m. Eastern Time
- Start time of Q2 2026 conference call
- Pre-call registration window
- 10 minutes
- Suggested minimum time to register before call start
- Replay availability delay
- 2 hours
- Approximate time after event when replay is posted
- Replay archive duration
- 2 weeks
- Length of time call replay remains on Investor Relations site
Previous Earnings date Reports
-
Announced Q1 2026 earnings release timing and accompanying conference call logistics.
-
Set date and time for Q4 and full year 2025 earnings release and call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, August 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2026 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q2 2026 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.